A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline. The aim of this Project is comercialize an innovative brain dedicated PET to facilitate the early detection of Alzheimer’s through β-amyloid plaque. Oncovision is the leader of this Project which has the collaboration fo relevant hospitals as the Massachusetts General Hospital and Hospital Clínico San Carlos. H2020-SMEINST-2-2015-711323. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 711323.